Comparative analysis of fructosamine and HbA1c as a glycemic control marker in Type 2 diabetes patients in a tertiary care hospital study
Background: Fructosamine (FA) is a marker of plasma glucose value that reveals the short-term glycemic level for 2–3 weeks. While measuring the plasma glucose level over 2–3 months with glycated hemoglobin (HbA1c) is a common practice. Aims and Objectives: This study aims to demonstrate the relat...
Main Authors: | Harshvardhan Patel, Anuradha N |
---|---|
Format: | Article |
Language: | English |
Published: |
Manipal College of Medical Sciences, Pokhara
2023-10-01
|
Series: | Asian Journal of Medical Sciences |
Subjects: | |
Online Access: | https://www.nepjol.info/index.php/AJMS/article/view/53962 |
Similar Items
-
Clinical usefulness of the measurement of serum fructosamine in childhood diabetes mellitus
by: Dong Soo Kang, et al.
Published: (2015-03-01) -
Status of Serum Fructosamine in Diabetic Subjects in Udaipur, Rajasthan
by: Avdhesh Kumar Sharma, et al.
Published: (2017-11-01) -
Serum fructosamine a better indicator than glycated hemoglobin for monitoring gestational diabetes mellitus
by: S Ayyappan, et al.
Published: (2015-01-01) -
Fructosamine and glycated hemoglobin level in pregnant women with abnormal glucose challenge test
by: Bostani Fargoosh P, et al.
Published: (2014-05-01) -
Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
by: Ji-Eun Lee
Published: (2015-06-01)